Using siRNA to suppress IL-32, the proliferation and survival of HCC cell lines is inhibited via classical p38 MAPK and NF-kB pathways, adding further evidence that IL-32 augments the development of HCC. Here, IL32 is linked to hepatocellular carcinoma.